Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objective To produce an improved, COPD-specific version of the St. George respiratory questionnaire (SGRQ-C).Methods Five different steps were required: (1) Rasch analysis of the responses of 893 COPD patients to the St. George respiratory questionnaire (SGRQ) identified weaker items to be removed; (2) a scoring algorithm was produced using data from 1,036 patients; (3) validity of the new and original SGRQ was tested using data from the original validation study; (4) responsiveness was tested using data from a previously published trial; and (5) a reworded version (SGRQ-C) that no longer specified the recall period was administered to 63 pulmonary rehabilitation participants.Results Items were removed due to lack of response (n = 1), misfit to the Rasch model (n = 8), and disordered responses (n = 1). Another six items had disordered responses; this was corrected. Scores from the two versions differed slightly, so the scoring algorithm was revised to produce scores equivalent to the original. Intraclass correlation coefficient (ICCC) for the scores for original and new versions was 0.99. Correlations with other measures of disease were very similar to those obtained with the original. New and original scores for treatment effects were similar: difference, 0.1 +/- 2.7 U (+/- SD). Baseline SGRQ and SGRQ-C scores were similar (ICCC, 0.95; 95% confidence interval, 0.92 to 0.97; mean difference, 0.9 +/- 5.8 U). Change scores were similar (difference, 1.0 +/- 7.3 U).Conclusions The SGRQ-C contains the best of the original items, no longer specifies a recall period, and produces scores equivalent to the original.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A review of the SGRQ undertaken to create a more appropriate instrument for use in patients with COPD identified 26 items that required modification.34”
From Cognitive behavioral therapy for management of dyspnea: A pilot study (2015) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Probabilistic Models for Some Intelligence and Attainment Tests
(1961) · Information and Control · doi:10.1016/s0019-9958(61)80061-2 · Cited by 6,939
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Self-citationAndrich, D. (1988) · doi:10.4135/9781412985598 · Cited by 1,345
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Self-citationDevelopment and validation of the Mini Asthma Quality of Life Questionnaire
Juniper, E. F., Guyatt, G. H., Cox, F. M., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a08.x · Cited by 786
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
Self-citationAmerican translation, modification, and validation of the St. George's Respiratory Questionnaire
Barr, J. T., Schumacher, G. E., Freeman, S., LeMoine, M., Bakst, A. W., & Jones, P. W. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80089-2 · Cited by 180
Self-citationBurge, P. S. (2003) · Thorax · doi:10.1136/thorax.58.8.654 · Cited by 154
Cited by
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Self-citationSusceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
“0.003 0.021 0.015 BMI (kg/m2) 26.7 (5.4) 27.7 (5.8) 0.007 26.0 (5.5) 26.3 (5.6) 0.415 24.3 (5.4) 25.4 (5.9) 0.140 0.001 0.001 FFMI (kg/m2) 17.4 (2.7) 17.6 (3.0) 0.339 17.0 (2.5) 17.0 (2.9) 0.387 16.4 (2.6) 16.4 (2.6) 0.986 0.008 0.001 mMRC Score 1.5 (1.0) 1.3 (1.0) 0.002 1.8 (1.0) 1.8 (1.1) 0.861 2.4 (1.0) 2.3 (1.0) 0…”
MethodInfluentialMepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., Martinot, J.-B., Sagara, H., Albers, F. C., Bradford, E. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708208 · Cited by 625
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1
Couper, D., LaVange, L. M., Han, M., Barr, R. G., Bleecker, E., Hoffman, E. A., Kanner, R., Kleerup, E., Martinez, F. J., Woodruff, P. G., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203897 · Cited by 394
Davey, C., Zoumot, Z., Jordan, S., McNulty, W. H., Carr, D. H., Hind, M. D., Hansell, D. M., Rubens, M. B., Banya, W., Polkey, M. I., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60001-0 · Cited by 362
Properties of the COPD assessment test in a cross-sectional European study
Jones, P. W., Brusselle, G., Dal Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., Perez, T., Soler Cataluña, J. J., van der Molen, T., Adamek, L., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00177210 · Cited by 341
Self-citationHospitalized Exacerbations of COPD
Müllerova, H., Maselli, D. J., Locantore, N., Vestbo, J., Hurst, J. R., Wedzicha, J. A., Bakke, P., Agusti, A., & Anzueto, A. (2015) · Chest · doi:10.1378/chest.14-0655 · Cited by 320
Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort
Hanania, N. A., Müllerova, H., Locantore, N. W., Vestbo, J., Watkins, M. L., Wouters, E. F. M., Rennard, S. I., & Sharafkhaneh, A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0472oc · Cited by 319
Brightling, C. E., Bleecker, E. R., Panettieri, R. A., Bafadhel, M., She, D., Ward, C. K., Xu, X., Birrell, C., & van der Merwe, R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70187-0 · Cited by 315
Patel, A. S., Siegert, R. J., Brignall, K., Gordon, P., Steer, S., Desai, S. R., Maher, T. M., Renzoni, E. A., Wells, A. U., Higginson, I. J., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201581 · Cited by 290
“Sixty-seven patients had CTD: scleroderma (24), undifferentiated CTD (14), systemic lupus erythematosis (9), polymyositis/ dermatomyositis (9), rheumatoid arthritis (6), mixed CTD (3) and Sjogren’s syndrome (2).”
BackgroundJones, P. W., Tabberer, M., & Chen, W.-H. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-42 · Cited by 280
Self-citationHealth-related quality of life in patients by COPD severity within primary care in Europe
Jones, P. W., Brusselle, G., Dal Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., Perez, T., Soler-Cataluña, J. J., van der Molen, T., Adamek, L., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.004 · Cited by 241
Self-citationINDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236
Jones, P. W., Adamek, L., Nadeau, G., & Banik, N. (2013) · European Respiratory Journal · doi:10.1183/09031936.00125612 · Cited by 210
“The primary aim of this analysis was to test the equivalence, assumed by GOLD, between these two symptom cut-points, by examining the relationship between health status scores and mMRC grades in patients with COPD in patients with a wide range of severity, using the Health-Related Quality of Life in COPD in Europe Stu…”
MethodSelf-citationPanahi, Y., Ghanei, M., Hajhashemi, A., & Sahebkar, A. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2014.952865 · Cited by 192
Metoprolol for the Prevention of Acute Exacerbations of COPD
Dransfield, M. T., Voelker, H., Bhatt, S. P., Brenner, K., Casaburi, R., Come, C. E., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Han, M. K., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908142 · Cited by 183
Leidy, N. K., Wilcox, T. K., Jones, P. W., Roberts, L., Powers, J. H., & Sethi, S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0762oc · Cited by 183
“‡ SGRQ-C scores range from 0–100, with higher scores indicating poorer health status. x EXACT scores range from 0–100, with higher scores indicating a more severe health state or exacerbation (n 5 196).”
BackgroundInfluentialSelf-citationMepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
Sciurba, F. C., Criner, G. J., Christenson, S. A., Martinez, F. J., Papi, A., Roche, N., Bourbeau, J., Korn, S., Bafadhel, M., Han, M. K., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2413181 · Cited by 164
Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement
Jones, P., Miravitlles, M., van der Molen, T., & Kulich, K. (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s32675 · Cited by 168
“Introduced in 2007, the COPD version of the SGRQ (SGRQ-C) is a revised and slightly shorter version specifically for COPD that produces scores directly analogous to those from the original.(69) It was revised using Rasch analysis of responses from COPD patients and validated using data from the original validation stu…”
Self-citationKarch, A., Vogelmeier, C., Welte, T., Bals, R., Kauczor, H.-U., Biederer, J., Heinrich, J., Schulz, H., Gläser, S., Holle, R., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.03.008 · Cited by 162
Jones, P. W., Harding, G., Wiklund, I., Berry, P., Tabberer, M., Yu, R., & Leidy, N. K. (2012) · Chest · doi:10.1378/chest.11-0309 · Cited by 161
Self-citationGimeno-Santos, E., Raste, Y., Demeyer, H., Louvaris, Z., de Jong, C., Rabinovich, R. A., Hopkinson, N. S., Polkey, M. I., Vogiatzis, I., Tabberer, M., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00183014 · Cited by 151
Yorke, J., Jones, P. W., & Swigris, J. J. (2010) · Thorax · doi:10.1136/thx.2010.139121 · Cited by 147
“com).(13) 19 Each of the three SGRQ components was tested separately.”
BackgroundMethodInfluentialSelf-citationA home telehealth program for patients with severe COPD: The PROMETE study
Calvo, G. S., Gómez‐Suárez, C., Soriano, J. B., Zamora, E., Gamarra, A. G., González-Bejar, M., Jordán, A., Tadeo, E., Sebastián, A. I., Fernández, G., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.12.003 · Cited by 160
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
Glaab, T., Vogelmeier, C., & Buhl, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-79 · Cited by 130
“A COPD-specific version is available [55].”
Farmer, A., Williams, V., Velardo, C., Shah, S. A., Yu, L.-M., Rutter, H., Jones, L., Williams, N., Heneghan, C., Price, J., et al. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7116 · Cited by 130
“Patient reported outcome measures 55.5 (16.2)56.4 (19.7)SGRQ-C (St George’s Respiratory questionnaire for COPD patients), mean (SD) 0.3 (0-0.5)0.3 (0.1-0.9)SCL-10Ai, median (IQR) 0.68 (0.3-1.1)0.53 (0.3-1.15)SCL-20j, median (IQR) 25.3 (5.7)24.6 (4.8)BMQ (Beliefs about Medicines Questionnaire), mean (SD) 22.5 (3.8)23.4…”
MethodInfluentialHuman airway branch variation and chronic obstructive pulmonary disease
Smith, B. M., Traboulsi, H., Austin, J. H. M., Manichaikul, A. W., Hoffman, E. A., Bleecker, E. R., Cardoso, W. V., Cooper, C. S., Couper, D. J., Dashnaw, S. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715564115 · Cited by 146
“In SPIROMICS, respiratory health status was assessed using the CAT (54) and the SGRQ-C, with higher scores indicating greater impairment (55).”
MethodThe COPD control panel: towards personalised medicine in COPD
Agustí, A. G. N., & MacNee, W. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202772 · Cited by 131
Wacker, M. E., Jörres, R. A., Karch, A., Wilke, S., Heinrich, J., Karrasch, S., Koch, A., Schulz, H., Watz, H., Leidl, R., et al. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0238-9 · Cited by 128
“HRQL was assessed by self-administered questionnaires: The St. George’s Respiratory Questionnaire in its COPDspecific version (SGRQ-C) [14] and the COPD Assessment Test (CAT) were used as disease-specific HRQL instruments, and the EuroQol 5 dimensions (EQ-5D-3 L) as a generic HRQL instrument.”
MethodInfluentialJoppa, P., Tkáčová, R., Franssen, F. M. E., Hanson, C., Rennard, S. I., Silverman, E. K., McDonald, M., Calverley, P. M. A., Tal‐Singer, R., Spruit, M. A., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.020 · Cited by 133
Sleep quality predicts quality of life in chronic obstructive pulmonary disease
Scharf, S. M., Maimon, N., Simon‐Tuval, T., Bernhard-Scharf, B. J., Reuveni, H., & Tarasiuk, A. (2010) · International Journal of COPD · doi:10.2147/copd.s15666 · Cited by 136
Zheng, Y., Zhu, J., Liu, Y., Lai, W., Lin, C., Qiu, K., Wu, J., & Yao, W. (2018) · BMJ · doi:10.1136/bmj.k4388 · Cited by 115
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial
Nagata, K., Horie, T., Chohnabayashi, N., Jinta, T., Tsugitomi, R., Shiraki, A., Tokioka, F., Kadowaki, T., Watanabe, A., Fukui, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0199oc · Cited by 120
“St. George’s Respiratory Questionnaire for COPD: Total, Symptom, Activity, and Impact Scores and other HRQOL Scores Only the total score at 24 weeks (P=0.044) and the impact score at 12 weeks (P=0.028) showed significant differences in the LSMs between the groups (Figure 3).”
MethodInfluentialNagata, K., Kikuchi, T., Horie, T., Shiraki, A., Kitajima, T., Kadowaki, T., Tokioka, F., Chohnabayashi, N., Watanabe, A., Satô, S., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201706-425oc · Cited by 113
Kaminsky, D. A., Guntupalli, K. K., Lippmann, J. E., Burns, S. M., Brock, M. A., Skelly, J. M., DeSarno, M., Pecott-Grimm, H., Mohsin, A., LaRock-McMahon, C., et al. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0102 · Cited by 143
“34 We collected exhaled breath condensate (EBC) for measurement of oxidative stress (hydrogen peroxide [H 2 O 2 ] 35 and 8-isoprostane 23 ) (by enzyme-linked immunosorbent assay [ELISA]; R&D Systems, Inc.), and blood for measurement of inflammation (C-reactive protein [CRP] 22 [by nephelometry,…”
Mesquita, R., Meijer, K., Pitta, F. D. O., Azcuna, H., Goërtz, Y. M. J., Essers, J. M. N. H., Wouters, E. F. �., & Spruit, M. A. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.029 · Cited by 129
Kenealy, T. W., Parsons, M. J. G., Rouse, A. P. B., Doughty, R. N., Sheridan, N. F., Hindmarsh, J. K. H., Masson, S. C., & Rea, H. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116188 · Cited by 102
“The St George Respiratory Questionnaire for COPD (SGRQ-C) [20, 21].”
MethodLee, H., Um, S., Kim, Y. S., Kim, D. K., Jang, A., Choi, H. S., Kim, Y. H., Kim, T. E., Yoo, K. H., & Jung, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156511 · Cited by 101
Martínez, F. J., Donohue, J. F., & Rennard, S. I. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61047-7 · Cited by 103
Calverley, P. M. A., Sethi, S., Dawson, M., Ward, C. K., Finch, D. K., Penney, M., Newbold, P., & van der Merwe, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0633-7 · Cited by 108
Jung, K. S., Park, H. Y., Park, S. Y., Kim, S. K., Kim, Y., Shim, J.-J., Moon, H. S., Lee, K. H., Yoo, J.-H., & Lee, S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.004 · Cited by 102
“George’s Respiratory Questionnaire for patients with COPD (SGRQ-C) and subscores of symptoms, activity, and impact in the SGRQ-C were analyzed.(14) An exacerbation was defined as symptomatic deterioration requiring the shortterm use of oral/intravenous steroids, antibiotics, or both, by the physician’s discretion.”
MethodTargeted lung denervation for moderate to severe COPD: a pilot study
Slebos, D., Klooster, K., Koegelenberg, C. F. N., Theron, J., Styen, D., Valipour, A., Mayse, M. L., & Bolliger, C. T. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206146 · Cited by 105
Evaluation of Quality of Life instruments for use in COPD care and research: A systematic review
Weldam, S. W. M., Schuurmans, M. J., Liu, R., & Lammers, J. J. (2012) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.07.017 · Cited by 100
Watz, H., Barnacle, H., Hartley, B. F., & Chan, R. H. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70200-5 · Cited by 103
COMET: a multicomponent home-based disease-management programmeversusroutine care in severe COPD
Kessler, R., Casán, P., Koehler, D., Tognella, S., Viejo, J. L., Negro, R. W. D., Lobato, S. D., Reissig, K., González-Moro, J. M. R., Devouassoux, G., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01612-2017 · Cited by 94
Agustí, A. G. N., Soler‐Cataluña, J. J., Molina, J., Muñoz, M. J., García-Losa, M., Roset, M., Jones, P., & Badia, X. C. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.692409 · Cited by 89
Self-citationCalder, P. C., Laviano, A., Lönnqvist, F., Muscaritoli, M., Öhlander, M., & Schols, A. M. W. J. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12228 · Cited by 100
McDowell, J. E., McClean, S., FitzGibbon, F., & Tate, S. (2015) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x14566575 · Cited by 90
“The primary outcome was quality of life, as measured by the St George’s Respiratory Questionnaire for COPD patients (SGRQ-C).(13) Secondary outcomes were the EuroQol five-dimension questionnaire (EQ-5D) score; anxiety and depression, as measured by a change in the Hospital Anxiety and Depression Scale (HADS); healthca…”
MethodLee, J. Y., Chon, G. R., Rhee, C. K., Kim, D. K., Yoon, H. K., Lee, J. H., Yoo, K. H., Lee, S. H., Lee, S. Y., Kim, T., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.4.553 · Cited by 89
“Quality of life and dyspnea scores The SGRQ-C was administered to assess the health status from the patient’s perspective (10).”
MethodProtein Biomarkers for COPD Outcomes
Serban, K. A., Pratte, K., & Bowler, R. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.004 · Cited by 90
Characterizing and Quantifying the Symptomatic Features of COPD Exacerbations
Jones, P., Chen, W.-H., Wilcox, T. K., Sethi, S., & Leidy, N. K. (2010) · CHEST Journal · doi:10.1378/chest.10-1240 · Cited by 81
Self-citationFarver-Vestergaard, I., Jacobsen, D., & Zachariae, R. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000367635 · Cited by 79
Development of the Japanese version of the COPD Assessment Test
Tsuda, T., Suematsu, R., Kamohara, K., Kurose, M., Arakawa, I., Tomioka, R., Kawayama, T., Hoshino, T., & Aizawa, H. (2012) · Respiratory Investigation · doi:10.1016/j.resinv.2012.05.003 · Cited by 87
“[8] Meguro M, Barley EA, Spencer S, et al.”
BackgroundMethodInfluentialDevelopment of the ATAQ-IPF: a tool to assess quality of life in IPF
Swigris, J. J., Wilson, S. R., Green, K. E., Sprunger, D. B., Brown, K. K., & Wamboldt, F. S. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-77 · Cited by 80
“To our knowledge, only one other investigator has used this type of approach in the development of respiratory disease-specific HRQL instruments [2,3].”
BackgroundMethodST GEORGE'S RESPIRATORY QUESTIONNAIRE MANUAL
Jones, P., & Forde, Y. (2009) · Cited by 80
Self-citationRojas, M. X., Morales, O. M. G., Dennis, R., & Karner, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008532.pub3 · Cited by 84
Lazaar, A. L., Miller, B. E., Donald, A., Keeley, T., Ambery, C. L., Russell, J. J., Watz, H., Tal‐Singer, R., for 205724 Investigators, Bardin, P. G., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01401-4 · Cited by 80
“Abbreviations AE: Adverse event; CAT: COPD Assessment test; CMH: Chronic mucus hypersecretion; COPD: Chronic Obstructive Pulmonary Disease; CPPAC: Clinic Visit PROactive Physical Activity in COPD; CXCR2: CXC chemokine receptor 2; DNX: Danirixin; Emax: Maximum observed efficacy; E-RS: COPD: Evaluating Respiratory Sympt…”
MethodSiler, T. M., Kerwin, E., Sousa, A. R., Donald, A., Ali, R. Z., & Church, A. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.006 · Cited by 74
Cazzola, M., Hanania, N. A., MacNee, W., Rüdell, K., Hackford, C., & Tamimi, N. (2015) · International Journal of COPD · doi:10.2147/copd.s77368 · Cited by 84
“SGRQ for COPD (SGRQ-C) The SGRQ-C is a 40-item version of the original 50-item SGRQ.(31) It was derived from the original version after a detailed analysis of data from large studies in COPD.”
MethodResultInfluentialMeasuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
Leidy, N. K., Sexton, C., Jones, P., Notte, S. M., Monz, B. U., Nelsen, L. M., Goldman, M. H., Murray, L. T., & Sethi, S. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204428 · Cited by 77
Self-citationLong-term Course of Depression Trajectories in Patients With COPD
Yohannes, A. M., Müllerová, H., Hanania, N. A., Lavoie, K., Tal‐Singer, R., Vestbo, J., Rennard, S. I., & Wouters, E. F. M. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.10.081 · Cited by 88
Slebos, D., Shah, P. L., Herth, F. J. F., Pison, C. M., Schumann, C., Hübner, R., Bonta, P. I., Kessler, R., Gesierich, W., Darwiche, K., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0624oc · Cited by 84
“George’s Respiratory Questionnaire (SGRQ-C; scores range from 0 to 100, with lower scores indicating better health-related quality of life; minimal clinically important difference [MCID], 4 points) (22, 23), EuroQoL 5-dimensions (EQ-5D-5L) (scores range from 0 to 1; MCID, 0.”
BackgroundHareendran, Leidy, N. K., Monz, Randall, Karin, & Mahler (2012) · International Journal of COPD · doi:10.2147/copd.s29571 · Cited by 85
Partridge, M. R., Miravitlles, M., Ståhl, E., Karlsson, N., Svensson, K., & Welte, T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00123709 · Cited by 62
The Impact of Cognitive Impairment on Efficacy of Pulmonary Rehabilitation in Patients With COPD
Cleutjens, F. A. H. M., Spruit, M. A., Ponds, R., Vanfleteren, L. E. G. W., Franssen, F. M. E., Dijkstra, J. B., Gijsen, C., Wouters, E. F. �., & Janssen, D. J. A. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.11.016 · Cited by 66
Activity Limitation and Quality of life In COPD
Jones, P. W. (2007) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701480265 · Cited by 61
Self-citationSolem, C. T., Sun, S. X., Sudharshan, L., Macahilig, C. P., Katyal, M., & Gao, X. (2013) · International Journal of COPD · doi:10.2147/copd.s51245 · Cited by 69
“The SGRQ-C is an adaptation of the SGRQ that was designed specifically to focus on COPD patients and their unique symptom profile.(20) The SGRQ-C provides a total score and also, component scores for Symptoms, Activities, and Impacts, each of which ranges from 0 to 100, with directionality such that higher scores refl…”
MethodViceconti, M., Penna, S. H., Dartee, W., Mazzà, C., Caulfield, B., Becker, C., Maetzler, W., García‐Aymerich, J., Davico, G., & Rochester, L. (2020) · Sensors · doi:10.3390/s20205920 · Cited by 66
“In COPD, the Saint-George Respiratory Questionnaire (SGRQ), which includes an activity domain assessing the effects of breathlessness on mobility and physical activity, is frequently used [18,19].”
Bremner, P. R., Birk, R., Brealey, N., Ismaila, A., Zhu, C., & Lipson, D. A. (2018) · Respiratory Research · doi:10.1186/s12931-018-0724-0 · Cited by 61
“The SGRQ for COPD patients [16] was completed by patients at randomization and Weeks 12 and 24.”
MethodLeidy, N. K., Murray, L. T., Jones, P., & Sethi, S. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201309-305oc · Cited by 57
Self-citationThe Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project
de Marco, R., Accordini, S., Antonicelli, L., Bellia, V., Bettin, M. D., Bombieri, C., Bonifazi, F., Bugiani, M., Carosso, A., Casali, L., et al. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000283034 · Cited by 62
Curtis, K. J., O’Brien, K. A., Tanner, R. J., Polkey, J. I., Minnion, M., Feelisch, M., Polkey, M. I., Edwards, L. M., & Hopkinson, N. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144504 · Cited by 56
Prevalence of obstructive lung disease in HIV population: A cross sectional study
Hirani, A., Cavallazzi, R., Vasu, T. S., Pachinburavan, M., Kraft, W. K., Leiby, B. E., Short, W. R., Desimone, J., Squires, K., Weibel, S., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.05.009 · Cited by 55
Partridge, M. R., Schuermann, W., Beckman, O., Persson, T., & Polanowski, T. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809344870 · Cited by 55
“…et al. 2003] in the evening before intake of study medication, reliever medication use was recorded throughout the study period and the modified St George’s Respiratory Questionnaire for COPD patients (SGRQ-C) was completed at the beginning and end of the treatment period [Meguro et al. 2007].”
MethodAl-shair, K., Müllerová, H., Yorke, J., Rennard, S. I., Wouters, E. F. �., Hanania, N. A., Sharafkhaneh, A., Vestbo, J., & for the ECLIPSE investigators (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-100 · Cited by 66
Consequences of chronic kidney disease in chronic obstructive pulmonary disease
Trudzinski, F. C., Alqudrah, M., Omlor, A., Zewinger, S., Fliser, D., Speer, T., Seiler, F., Biertz, F., Koch, A., Vogelmeier, C. F., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1107-x · Cited by 61
Yohannes, A. M., Mülerová, H., Lavoie, K., Vestbo, J., Rennard, S. I., Wouters, E. F., & Hanania, N. A. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.05.024 · Cited by 58
Agustí, A. G. N., de Teresa, L., Backer, W. D., Zvarich, M. T., Locantore, N., Barnes, N. C., Bourbeau, J., & Crim, C. C. (2013) · European Respiratory Journal · doi:10.1183/09031936.00054213 · Cited by 52
Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
Scharf, S. M., Geiger-Brown, J. M., Lindberg, S. M., Krachman, S. L., McEvoy, C., Criner, G. J., Connett, J. E., & Albert, R. K. (2015) · International Journal of COPD · doi:10.2147/copd.s75840 · Cited by 52
Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
Duenk, R. G., Verhagen, C., Bronkhorst, E. M., van Mierlo, P., Broeders, M., Collard, S., Dekhuijzen, P. N. R., Vissers, K. C. P., Heijdra, Y. F., & Engels, Y. (2017) · International Journal of COPD · doi:10.2147/copd.s141974 · Cited by 61
“There was a significant difference between groups in the change scores of the impact subscale of the SGRQ at 6 months ( − 5.73 [16.21] vs 0.86 [18.73], p = 0.04).”
InfluentialValidity of the COPD Assessment Test Translated Into Local Languages for Asian Patients
Kwon, N., Amin, M., Hui, D. S. C., Jung, K., Lim, S. Y., Ta, H. D., Thai, T. T. L., Yunus, F., & Jones, P. (2013) · CHEST Journal · doi:10.1378/chest.12-0535 · Cited by 58
Self-citationLee, H. J., Jhun, B. W., Cho, J., Yoo, K. H., Lee, J. H., Kim, D. K., Lee, J. D., Jung, K., Lee, J. Y., & Park, H. Y. (2017) · International Journal of COPD · doi:10.2147/copd.s145910 · Cited by 51
“High SGRQ-C score and low SGRQ-C score were defined as SGRQ-C score $25 and SGRQ-C score ,25, respectively.(3,22)”
InfluentialAlma, H., de Jong, C., Jelusic, D., Wittmann, M., Schuler, M., Blok, B. F.-D., Kocks, J., Schultz, K., & Molen, T. V. D. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2016.41 · Cited by 49
“A study by Meguro et al.(32) compared the shorter SGRQ-C without recall period with the original SGRQ with a specified 4week recall period.”
MethodAl-shair, K., Atherton, G. T., Kennedy, D., Powell, G., Denning, D. W., & Caress, A. (2013) · CHEST Journal · doi:10.1378/chest.12-0014 · Cited by 52
Cleutjens, F. A. H. M., Spruit, M. A., Ponds, R., Vanfleteren, L. E. G. W., Franssen, F. M. E., Gijsen, C., Dijkstra, J. B., Wouters, E. F. �., & Janssen, D. J. A. (2017) · Chronic Respiratory Disease · doi:10.1177/1479972317709651 · Cited by 53
“The SGRQ-C provides a total score and three domain scores: symptoms, activities, and impact (ranging from 0 [best] to 100 points [worst]).(18) Symptoms of anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS).”
MethodGhosh, B., Gaike, A. H., Pyasi, K., Brashier, B. B., Das, V., Londhe, J. D., Juvekar, S. K., Shouche, Y. S., Donnelly, L., Salvi, S., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02273-2017 · Cited by 46
Kharbanda, S., & Anand, R. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1812_18 · Cited by 52
Variability of within-breath reactance in COPD patients and its association with dyspnoea
Aarli, B. B., Calverley, P. M. A., Jensen, R. L., Eagan, T., Bakke, P. S., & Hardie, J. A. (2014) · European Respiratory Journal · doi:10.1183/09031936.00051214 · Cited by 52
“collected [19].”
Taniguchi, H., Morishita, M., Nishimura, K., Kimura, T., Kondoh, Y., Kataoka, K., Ogawa, T., Watanabe, F., Arizono, S., Nishiyama, O., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s104947 · Cited by 47
“Given this, it is important to determine if the CAT can be used as a suitable substitute for SGRQ.”
InfluentialKunisaki, K. M., Niewoehner, D. E., Collins, G., Aagaard, B., Atako, N. B., Bąkowska, E., Clarke, A. E., Corbelli, G. M., Ekong, E., Emery, S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30319-8 · Cited by 44
Jones, P., Brusselle, G., Negro, R. W. D., Ferrer, M., Kardos, P., Levy, M. L., Perez, T., Soler‐Cataluña, J. J., van der Molen, T., Adamek, L., et al. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00065 · Cited by 47
Self-citationNinot, G., Soyez, F., & PREFAUT, C. G. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-179 · Cited by 52
“Significant correlations were found between the psychological component of the VQ11 and the HADS anxiety and depression scales, the SGRQ-C impact scale, the emotional role and mental components of the SF36, and physical self-worth (defined as physical self-esteem).”
BackgroundMethodInfluentialClinical phenotypes of COPD and health-related quality of life: a cross-sectional study
Chai, C.-S., Liam, C. K., Pang, Y., Ng, D. L.-C., Beng, T. S., Wong, T. S., & Sia, J.-E. (2019) · International Journal of COPD · doi:10.2147/copd.s196109 · Cited by 43
“The SGRQ-c questionnaire consists of 14 questions, with questions 1–7 interrogating the symptom component, questions 9 and 12 concerning activity component, and questions 8, 10, 11, 13, and 14 relating to impact component.(23) The score of each component and the total score range from 0% to 100%, with a higher score r…”
Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients
Valipour, A., Shah, P. L., Pison, C. M., Ninane, V., Janssens, W., Perez, T., Kessler, R., Deslée, G., Garner, J. L., Abele, C., et al. (2019) · Respiration · doi:10.1159/000500463 · Cited by 44
Norheim, K. L., Ezra, M. B., Heckenbach, I., Andreasson, L. M., Eriksen, L. L., Dyhre‐Petersen, N., Damgaard, M. V., Berglind, M., Pricolo, L., Sampson, D. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00758-1 · Cited by 53
“Symptom severity was measured in the patients with COPD using the CAT 16 and the St. Georges Respiratory Questionnaire (SGRQ-C) 42 , and general health status was measured using the EuoQol 5-Dimension Questionnaire (EQ-5D-5L) 43 .”
Cheng, L., Tan, B., Yin, Y., Wang, S., Jia, L., Warner, G., Jia, G., & Jiang, W. (2018) · Clinical Rehabilitation · doi:10.1177/0269215518779122 · Cited by 41
Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
Afroz, N., Gutzwiller, F. S., Mackay, A. J., Naujoks, C., Patalano, F., & Κostikas, Κ. (2020) · International Journal of COPD · doi:10.2147/copd.s235845 · Cited by 41
Papp, C., Pák, K., Erdei, T., Juhász, B., Seres, I., Szentpéteri, A., Kardos, L., Szilasi, M., Gesztelyi, R., & Zsuga, J. (2017) · International Journal of COPD · doi:10.2147/copd.s135701 · Cited by 42
“37 SGRQ quantifies health impairment with three-component scores and one total score.”
InfluentialIntestinal function is impaired in patients with Chronic Obstructive Pulmonary Disease
Kirschner, S. K., Deutz, N. E. P., Jonker, R., Damink, S. W. M. O., Harrykissoon, R., Zachria, A. J., Dasarathy, S., & ENGELEN, M. P. K. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.010 · Cited by 44
Metadata
- Authors
- Meguro, M., Barley, E. A., Spencer, S., & Jones, P. W.
- Affiliations
- St George's, University of London (GB)
- Brunel University of London (GB)
- Corresponding author
- Jones, Paul W.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 132
- Issue
- 2
- Pages
- 456-463
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2026656842
- Cited by
- 350
- References
- 16
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 12 · 2021: 29 · 2020: 26 · 2019: 20 · 2018: 27 · 2017: 36 · 2016: 33 · 2015: 24 · 2014: 22 · 2013: 18 · 2012: 17
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Edge Hill University Research Information Repository (Edge Hill University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- St George's Respiratory Questionnaire, chronic obstructive pulmonary disease, Rasch analysis, scoring algorithm, questionnaire validity, responsiveness, pulmonary rehabilitation, patient-reported outcomes
- MeSH terms
- Aged, Algorithms, Cross-Sectional Studies, Female, Follow-Up Studies, Health Status, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.